Quantcast

Latest Microsphere Stories

2011-12-02 18:26:08

Spatiotemporal signals guide stem cell changes A lab discovery is a step toward implantable replacement cartilage, holding promise for knees, shoulders, ears and noses damaged by osteoarthritis, sports injuries and accidents. Self-assembling sheets of mesenchymal stem cells permeated with tiny beads filled with growth factor formed thicker, stiffer cartilage than previous tissue engineering methods, researchers at Case Western Reserve University have found. A description of the research...

2011-08-16 07:40:00

Corporate Pledge of $50,000 Supports Major Fund-raising Initiative to Expand Minimally Invasive Medicine Into New Areas of Discovery FAIRFAX, Va., Aug. 16, 2011 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology Foundation's Discovery Campaign, which seeks to further the growth of minimally invasive medicine into new areas of discovery, announced a major corporate pledge to that initiative. Sirtex Medical Inc.--a medical devices company that researches, develops and brings...

2011-06-29 06:50:00

SAN DIEGO, June 29, 2011 /PRNewswire/ -- Suneva Medical, a privately-held aesthetic medical device company, today announced the expansion of its core aesthetics injectable business with approval from Health Canada to market Bellafill((TM)), its long lasting dermal filler for nasolabial folds or smile line correction. In addition to offering patients a unique, long-lasting treatment, Bellafill provides physicians the opportunity to provide a differentiated, premium product and enhance their...

2011-04-18 13:06:26

For the first time, scientists have made star-shaped, biodegradable polymers that can self-assemble into hollow, nanofiber spheres, and when the spheres are injected with cells into wounds, these spheres biodegrade, but the cells live on to form new tissue. Developing this nanofiber sphere as a cell carrier that simulates the natural growing environment of the cell is a very significant advance in tissue repair, says Peter Ma, professor at the University of Michigan School of Dentistry and...

2010-07-27 08:00:00

AUSTIN, Texas, July 27 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX), the worldwide leader in multiplexed solutions, today announced the global launch of MAGPIX®, an analytical instrument that is capable of performing up to 50 tests on a single sample and providing nearly 5,000 data points in under an hour. EMD Millipore (Billerica, MA) is the first value-added reseller that will distribute the MAGPIX instrument worldwide. The instrument was designed to...

2010-05-11 16:28:00

EDMONTON, May 11 /PRNewswire/ - IMBiotechnologies Ltd. ("IMBio"), a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration (FDA) to market its lead product, Occlusin(R) 500 Artificial Embolization Device (OCL 500) in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours. IMBio filed the...

2010-04-29 14:21:27

New research in the FASEB Journal reports that fluorescent microspheres conjugated to cell surface molecules can detect early inflammation at the molecular level Forget what you know about how diseases are diagnosed"”new research published in the May 2010 print issue of The FASEB Journal details a noninvasive ground-breaking tool that detects signs of disease at early molecular stages before symptoms can be seen using traditional methods. Even better, this tool promises to detect some...

2010-01-19 17:21:00

ATLANTA, Jan. 19 /PRNewswire/ -- Professor Franco Orsi, MD, Medical Director of the Unit of Interventional Radiology at the European Institute of Oncology was awarded The Symposium on Clinical Interventional Oncology 2010 Best Poster Award by Dr. Shaun Samuels, Lead Course Director, for his poster presentation entitled; Micro-Bland Embolization Combined with Radiofrequency Ablation for Treating Complex Hepatic Tumors. Orsi's poster as well as an oral abstract, were presented to a capacity...

2009-12-01 12:55:00

NEWNAN, Ga., Dec. 1 /PRNewswire/ -- CeloNova BioSciences, Inc., a provider of specialty surface treatments for medical devices and of specialty implants, today announced that President and Chief Executive Officer, Thomas A. Gordy, will give an opening address for the Technology Parade at the Innovations in Cardiovascular Interventions Conference in Tel Aviv, Israel. "We must leave the era of petty self-interest behind and focus the rich intellectual resources of the health care industry...

2009-10-30 17:47:00

NEWNAN, Ga., Oct. 30 /PRNewswire/ -- CeloNova BioSciences today announced that the company is submitting to its European Notified Body a request for approval of its new, lime green, 2800 micron size Embozene(TM) Microsphere. (Photo: http://www.newscom.com/cgi-bin/prnh/20081007/CLTU035-b) (Logo: http://www.newscom.com/cgi-bin/prnh/20081001/CLW080LOGO-b) Embozene(TM) Color-Advanced Microspheres are spherical embolics approved in Europe for the treatment of liver cancer, uterine fibroids,...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related